Blocked Bacteria: Researchers discover a new target against tuberculosis

Laura Gödl and Lina Riegler-Berket, together with a team led by Monika Oberer, have discovered a new target for attacking tuberculosis. Photo: University of Graz/Leljak.

Researchers at the University of Graz have deciphered the structure of an enzyme that enables “dormant” tuberculosis bacteria to survive. For the first time, they have now identified a compound that disrupts the bacteria’s fat metabolism in this state. These discoveries could pave the way for shorter and more effective therapies against the infectious disease.

Each year, more than one million people worldwide die from tuberculosis — the infectious disease that claims more lives than any other. Treatment lasts at least six months and often fails because patients discontinue the lengthy antibiotic regimen, leading to dangerous resistances. The bacteria are particularly difficult to treat when they “hide” in granulomas. “Granulomas are tiny protective capsules formed by our immune system when it cannot completely eliminate pathogens. Inside them, the bacteria retreat and enter a kind of dormant state. In this hideout, they are hard for drugs to reach,” explains molecular biologist Lina Riegler-Berket.

Blocked in their sleep

This is precisely where a current study comes in: The research team at the University of Graz, together with international partners and the biotech company Innophore, has identified an enzyme that tuberculosis bacteria need for their fat metabolism during this resting phase. “In addition, we have discovered a drug candidate that blocks this enzyme while the bacteria are in their ‘sleeping’ state. This small step subsequently disrupts the entire fat metabolism of the bacterium, thereby reducing its ability to survive,” says Riegler-Berket. The research findings could form the basis for revising existing antibiotics, with the goal of shortening treatment durations in the future.

Artificial intelligence as a key factor

A decisive role in the study was played by the collaboration with the company Innophore. The firm, a spin-off from the University of Graz, used AI-based analyses to investigate the similarities between the bacterial enzyme and its human counterpart. This made it possible to rule out early on that potential compounds would cause unwanted side effects in humans. “AI can help us filter from billions of possible molecular structures those that might fit best — a step that significantly accelerates our research,” the scientist explains.

Publication:

M. tuberculosis meets European Lead Factory – Identification and structural characterization of novel Rv0183 inhibitors using X-ray crystallography. Riegler-Berket, Lina and Gödl, Laura et al. Disease and Therapeutics. 1 (2025): 100002. DOI: 10.1016/j.dist.2025.100002

Would you also like to understand how bacteria work? You can find out by studying molecular biology!

Related news

Fair distribution: Researchers determine just greenhouse gas budgets for all EU regions

Ten years ago, on 12 December 2015, the Paris Climate Agreement was signed at the UN Climate Conference. In order to limit global warming to well below two degrees, only a certain amount of CO2 may be emitted worldwide. While the focus was originally on national emission targets, more than 200 subnational regions and almost 300 cities have now adopted their own targets. But how many emissions are they fairly entitled to? Researchers at the University of Graz have now developed transparent criteria for fair distribution at the subnational level for the first time and determined corresponding greenhouse gas budgets for all European regions. The paper was published today in the scientific journal Nature Communications.

Chemical Christmas show at the University of Graz: An explosive evening at the Schauspielh

At the beginning of December, the University of Graz transformed the theater into a laboratory: as part of “Chemical Life,” teacher training students staged a chemical Christmas show for Styrian school classes—complete with ethanol rockets, nitrogen snow, and glowing effects. An evening designed to inspire interest in studying chemistry.

Train by train: Koralm railway accelerates exchange between the Universities

Lectures at the University of Klagenfurt in the morning, seminars at the University of Graz in the afternoon: Austria's longest tunnel and a journey time of around 45 minutes make it easy. The Koralm railway increases the speed of networking between the two university locations. The collaboration builds on existing cooperation - for example in the areas of teacher training, Slavic studies and as employers, the universities are well coordinated.

On the trail of the Big Bang: University of Graz receives 1.5 million euros for doctoral programmes

The Austrian Science Fund FWF has selected the Doctoral Programme in Theoretical Particle Physics at the University of Graz for funding from the Doc.funds. Six young scientists will be funded for 3.5 years. They will gain fundamentally new insights into the origins of the world.